Objectives: To evaluate the systematic chain of care for patients with acute STelevation myocardial infarction (STEMI) referred for primary angioplasty in a capital city in Midwestern Brazil.
In order to provide an ideal treatment for patients with AMI, with appropriate onset-to-balloon and door-to-balloon times, a chain of events must be sequentially linked in a systematic manner. 16, 17 In view of the foregoing, our primary objective was to evaluate the systematic chain of care for patients with acute ST-elevation myocardial infarction (STEMI) referred for primary angioplasty in a capital city in Midwestern Brazil. A secondary objective was to indicate strategies to optimize care for STEMI patients.
| METHODS
This was a descriptive study with retrospective data collection of all patients aged 18 years or over with STEMI admitted to two tertiary care centers from March 2012 to June 2014 in Goiânia, city and capital of Goiás, a state in Midwestern Brazil. Both hospitals are the referral centers for patients requiring specialized invasive cardiac treatment and, together, treat nearly all cases of acute coronary syndrome in Goiânia through the Brazilian Unified Health System, which is a government-funded universal health care system that includes the public provision of core physician and hospital services without copayments or patient charges. 1, 2 The study was approved by the Research Ethics Committee of our institution, under protocol number 007/2012. Informed consent was waived due to the retrospective nature of data collection.
All STEMI patients included in the study were referred to the participating tertiary care centers by the Goiânia municipal control and assessment service, which is the regional referral pole and receives notifications of cases of AMI from the entire Midwest region of Brazil. The path followed by STEMI patients through the service network is as follows: (1) patient goes to walk-in centers in the city, either by themselves or by ambulance, where STEMI is diagnosed-it is important to note that many of these centers do not have an on-call cardiologist or even a chest pain unit; (2) the physician in charge of the city's control and assessment service is notified; and (3) the physician allocates the patient to hospitals that have the capacity to treat STEMI patients, providing the admitting hospital with detailed information on each case. Patients are only transferred after the transfer process has been properly authorized and documented so that, when patients arrive at the tertiary hospitals, specialized teams that are available 24 h a day have been informed of the case in advance and are ready to treat the patient with specific medication and invasive treatment (primary angioplasty). Fibrinolysis is only performed when the cardiovascular intervention unit is unavailable to treat the case in a timely manner.
Otherwise, all patients are treated with primary angioplasty.
The patients' medical records were reviewed for data on sex, age, hypertension, current smoking, diabetes, time elapsed between symptom onset and arrival at the tertiary hospital with the capacity to perform primary angioplasty (delta-T), and time elapsed between arrival at the tertiary hospital and vessel recanalization by primary angioplasty (door-to-balloon time). All patients had clinical symptoms of chest pain, an electrocardiogram (ECG) with ST-segment elevation, and elevated biochemical markers of acute myocardial injury. Non-STEMI cases were excluded.
Patients with STEMI requiring primary angioplasty were preferably treated using the femoral technique, although a small number of cases were treated using the radial technique. The choice of access route was based primarily on the availability of the materials needed for the respective procedures. All patients treated with primary angioplasty underwent coronary stent placement after mechanical recanalization of the target vessel. After the procedure, patients received dual antiplatelet therapy with acetylsalicylic acid (100 mg/ day) and clopidogrel (75 mg/day). Patients were discharged only after meeting the clinical criteria of stability for outpatient management.
All collected data were entered into a spreadsheet and analyzed using SPSS, version 20.0. The Shapiro-Wilk test was used to assess the normality of data distribution. Spearman's correlation coefficients were calculated to test the relationship between mortality and delta-T.
A logistic regression analysis was used to investigate the time interval between onset of pain and primary angioplasty (in the group of patients treated within 12 h of symptom onset) as a predictor of mortality. P-values <0.05 were considered significant.
| RESULTS
During the study period, 835 patients with STEMI were treated at the two tertiary referral centers in Goiânia and included in the study. Of these, 67% (560) were men and 33% (275) were women, with a median age of 52 years. Current smoking was reported by 57% (480) of patients. Hypertension was present in 57% (472) of cases, and diabetes was present in 46% (388) of cases. A cardiovascular unit team was available at all times, and fibrinolysis was not performed in any case.
Of 835 STEMI patients, only 6% (52) arrived within 12 h of the onset of infarction. More than half of the patients (61%) had been symptomatic for more than 24 h ( Figure 1 ).
Median delta-T was 32 h. Among patients with a delta-T of less than 12 h who were immediately treated with primary angioplasty, median door-to-balloon time was 37 min. There were no door-toballoon times exceeding 60 min.
Among patients who arrived within 12 h of symptom onset for treatment, the length of time between onset of pain and primary angioplasty was identified as a predictor of mortality in univariate logistic regression analysis (P = 0.003), but not as an independent predictor of this outcome in the multivariate analysis (P = 0.15).
Regarding access routes, 88% (46) of procedures were performed via femoral access and 12% (6) via radial access. Primary angioplasty was successful in 100% of cases. However, 6 of the 52 patients subjected to early intervention died during the first 30 days of clinical follow-up, and mortality was significantly correlated with a delta-T greater than 8 h (P < 0.03; r = 0.68). All deaths were caused by STEMI- Median delta-T was 32 h, and only 6% (52) of patients were treated at a tertiary care center within 12 h of symptom onset. Even more alarming is the fact that 61% (507) of patients received specialized care more than 24 h after the onset of acute symptoms.
Of 52 patients treated at the tertiary care centers within 12 h of symptom onset, 51 underwent percutaneous treatment and their median door-to-balloon time was 37 min. This time is within the interval recommended by national and international guidelines for STEMI treatment, that is, less than 90 min. [10] [11] [12] [13] 17 Although the time Also, there are situations in which the patient feels no pain, but anginal equivalents such as dyspnea, syncope, and vomiting. All of these situations, which are primarily dependent on the patient, will remain a challenge for the initial links of AMI care, especially among older patients, diabetics, and those with heart failure or artificial pacemakers. 10 Therefore, public and private initiatives should be taken in conjunction to promote programs aiming to raise public awareness of early recognition of chest pain and its equivalents and to encourage people to seek emergency medical care. This would constitute a first step towards correcting failures present in the initial links of the chain of care for STEMI patients. 16 The public health system in Brazil is organized in a decentralized, hierarchical manner to provide care to the population. 1,2 Once patients recognize the clinical signs of chest pain, they must seek care at a primary care center, where, after initial evaluation, they will be given first aid. Once a diagnosis of STEMI is made in the primary care center, the next step should be to arrange for recanalization of the occluded vessel as soon as possible. However, several factors related to the primary care centers have been found to delay progress through the initial links of the chain of AMI care, including dilemma over the interpretation of the clinical status of the patient, inconclusive ECGs, FIGURE 1 Schematic illustration of treatment provided in the cases of AMI included in the study. Participating centers located in Goiânia, Goiás, Brazil. ΔT, time elapsed between symptom onset and arrival at the tertiary care center; AMI, acute myocardial infarction and, particularly, delays in transferring patients to specialized centers. [18] [19] [20] In the HORIZONS-AMI trial, the most powerful independent predictor of cardiovascular events was the interval between symptom onset and arrival at a specialized hospital: the longer the interval, the worse the prognosis. 18 In this scenario, which is similar to that reported in the present study, improving screening for early diagnosis, whether at the primary care center or even in the ambulance (pre-hospital electrocardiographic diagnosis of AMI by physicians or paramedics), can shorten the length of time that elapses before access to primary angioplasty, allowing patients with STEMI who live far away from a tertiary hospital to receive specialized treatment in a timely manner, similar to patients who live close to a referral center. 18 In the present study, although mortality among patients who underwent primary angioplasty was correlated with a delta-T between 8 and 12 h, this time interval did not reach the statistical significance necessary to be considered a predictor of mortality (P = 0.145).
The health professionals who are the first care providers for patients with AMI should therefore be given complete and comprehensive training. Preparing these professionals to make early diagnoses and to rapidly and safely transfer patients to tertiary hospitals is a goal to be achieved in programs for AMI treatment, and should be a target of Brazilian public-private initiatives. Regional networks should be set up for AMI care, effectively integrating emergency medical services, primary care centers, and tertiary hospitals with the capacity to perform primary angioplasty.
16,18-21
Deficiencies in access to primary angioplasty in a timely manner are not exclusive to Brazil or even to less developed countries. In 2008, the European Society of Cardiology (ESC), in conjunction with the European Association of Percutaneous Cardiovascular Interventions (EAPCI), launched the "Stent for Life" initiative to document and correct differences in opportunities to access primary angioplasty and to achieve universal implementation of the guidelines for AMI treatment in Europe. 16, 20, [22] [23] [24] [25] The first step was to diagnose the current situation of reperfusion treatment for AMI on the continent. The results of a register with data from more than 30 countries revealed large regional disparities in the implementation of primary angioplasty. 24, 25 The points at which the chain of AMI care failed were highlighted (Table 1 ) and used as the basis to propose organizational models that could be adapted to the different requirements of European countries and their diverse health systems, to the structure of their emergency care services, and to the availability of hospitals with the capacity to provide treatment. National and regional solutions were then tailored to meet these needs and implemented. As a result, less than 4 years after the project was launched, primary angioplasty had become the reperfusion treatment of choice for AMI in most European countries. The bottom line is that this is also the purpose of the present research: to raise awareness of the true situation of emergency AMI care in the central region of Brazil and suggest strategies to optimize the chain of AMI care in this and other regions where treatment is not at the desired level. 24 Brazil is a country of continental dimensions, with a highly heterogeneous distribution of the population. Each region has a specific economic situation and particular cultural habits, which directly influence the type and quality of medical care available in the different areas of the country, especially in more remote areas. However, like in the "Stent for Life"
initiative, commitment to providing adequate guidance, with care tailored to the needs of specific regions, could be the solution to creating a culture of adequate treatment of STEMI in Brazil. 24, 25 In Brazil by noting whether evidence-based goals were being achieved. [26] [27] [28] The Registry showed that the mean delta-T was close to 5 h, which is very different from the time of 28 ± 5.1 h observed in the present study, with a median of 37 h. It is worth pointing out that the Midwest region was only represented in the Registry by three cardiology units, accounting for a smaller number of patients than that of other regions of Brazil. However, the Registry also showed that door-to-balloon time was greater than 90 min in 60% of cases, whereas, in the present study, all 51 cases had door-to-balloon times of less than 60 min.
26-28
The results of the present study are therefore very different from those found in the Brazilian Registry of AMI treatment, and reflect the chaotic way in which this condition, which is a public health problem, is being managed in some parts of the country. Moreover, although the results from the Brazilian Registry discussed here offer a general panorama of AMI care in Brazil, it is possible that they do not reflect regional variations within the country, with more specific characteristics such as those reported in the present study. Therefore, a systematic national campaign aimed at sensitizing and raising awareness in the community, in combination with efforts to ensure solid technical and scientific training for health professionals on how to treat patients with STEMI, would benefit not only affected patients but also the whole society.
| CONCLUSIONS
Treatment of STEMI through the public health system in Goiânia falls short of the targets recommended for STEMI treatment. Potentially reversible failures were observed in the initial links of the chain of care
for STEMI patients, and their resolution would have a major impact on improving patient prognosis and reducing the health care burden.
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